Free Trial

Dolby Laboratories, Inc. (NYSE:DLB) Shares Bought by Dimensional Fund Advisors LP

Dolby Laboratories logo with Consumer Discretionary background

Dimensional Fund Advisors LP raised its position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 3.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 901,707 shares of the electronics maker's stock after purchasing an additional 31,164 shares during the period. Dimensional Fund Advisors LP owned about 0.94% of Dolby Laboratories worth $70,424,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Fifth Third Bancorp grew its holdings in Dolby Laboratories by 82.7% during the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after buying an additional 163 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Dolby Laboratories by 436.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after acquiring an additional 301 shares during the last quarter. Mather Group LLC. increased its position in Dolby Laboratories by 36.8% during the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock worth $41,000 after purchasing an additional 142 shares in the last quarter. Headlands Technologies LLC purchased a new position in Dolby Laboratories in the 4th quarter valued at about $57,000. Finally, GAMMA Investing LLC grew its holdings in shares of Dolby Laboratories by 207.5% during the fourth quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock worth $61,000 after buying an additional 525 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Rosenblatt Securities reduced their target price on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research report on Friday. Barrington Research restated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Friday. Finally, StockNews.com lowered Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st.

View Our Latest Stock Report on DLB

Insider Activity at Dolby Laboratories

In other news, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $84.07, for a total transaction of $588,490.00. Following the sale, the chief accounting officer now owns 29,758 shares of the company's stock, valued at approximately $2,501,755.06. The trade was a 19.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CMO Todd Pendleton sold 18,121 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $83.75, for a total value of $1,517,633.75. Following the completion of the transaction, the chief marketing officer now directly owns 37,290 shares of the company's stock, valued at $3,123,037.50. This trade represents a 32.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 38.39% of the stock is currently owned by insiders.

Dolby Laboratories Stock Performance

Shares of NYSE DLB traded down $0.15 during trading on Tuesday, reaching $74.56. The stock had a trading volume of 52,093 shares, compared to its average volume of 451,671. The firm's 50 day moving average price is $77.59 and its two-hundred day moving average price is $78.37. Dolby Laboratories, Inc. has a one year low of $66.35 and a one year high of $89.66. The stock has a market cap of $7.12 billion, a PE ratio of 27.46 and a beta of 0.94.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share for the quarter, topping analysts' consensus estimates of $1.29 by $0.05. Dolby Laboratories had a return on equity of 11.32% and a net margin of 19.97%. The business had revenue of $369.56 million for the quarter, compared to analysts' expectations of $375.44 million. During the same period in the prior year, the firm earned $1.27 EPS. The business's quarterly revenue was up 1.4% on a year-over-year basis. On average, research analysts expect that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 21st. Investors of record on Tuesday, May 13th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.77%. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.53%.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Articles

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines